Compare NLOP & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NLOP | KRMD |
|---|---|---|
| Founded | N/A | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 164.9M | 192.5M |
| IPO Year | 2022 | 2019 |
| Metric | NLOP | KRMD |
|---|---|---|
| Price | $9.66 | $2.92 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.25 |
| AVG Volume (30 Days) | 152.1K | ★ 269.1K |
| Earning Date | 11-06-2026 | 11-11-2026 |
| Dividend Yield | ★ 3.52% | N/A |
| EPS Growth | N/A | ★ 53.85 |
| EPS | ★ 1.27 | N/A |
| Revenue | ★ $118,915,000.00 | $41,127,366.00 |
| Revenue This Year | N/A | $16.78 |
| Revenue Next Year | N/A | $17.22 |
| P/E Ratio | $7.63 | ★ N/A |
| Revenue Growth | N/A | ★ 22.23 |
| 52 Week Low | $9.51 | $2.86 |
| 52 Week High | $30.26 | $6.61 |
| Indicator | NLOP | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 28.04 | 32.32 |
| Support Level | $9.51 | $2.86 |
| Resistance Level | $11.65 | $3.41 |
| Average True Range (ATR) | 0.24 | 0.14 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 13.27 | 10.38 |
Net Lease Office Properties is a Maryland real estate investment trust that, together with its consolidated subsidiaries, owns, operates, and finances a diversified portfolio of office properties mainly leased to corporate tenants on a single-tenant, net-lease basis. The company operates as a single operating and reportable segment focused on owning and managing office properties that generate revenue mainly from long-term lease agreements with tenants.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.